Proteostasis
A cell's ability to maintain balance between protein production, correct folding, and degradation — a network of mechanisms whose capacity declines with age and is studied as one of the fundamental pillars of cellular aging.
Number of studies
2
Safety
High
Time to effects
Not applicable as a single intervention — this is a descriptive biological framework covering many overlapping processes with different time dynamics.
Who it's for
Table of contents
TL;DR
A cell's ability to maintain balance between protein production, correct folding, and degradation — a network of mechanisms whose capacity declines with age and is studied as one of the fundamental pillars of cellular aging.
- →Prevents the accumulation of misfolded and damaged proteins within the cell
- →Provides a theoretical framework linking many other studied aging mechanisms (autophagy, UPRmt, lysosomal function)
- →Good proteostasis is studied as a factor protecting against the accumulation of protein aggregates characteristic of neurodegenerative diseases (mainly data from animal models)
| Process type | A network of mechanisms maintaining the balance of protein synthesis, folding, and degradation |
|---|---|
| Research level | Moderate — strong mechanistic evidence from animal models and human cell lines, no direct clinical interventions in humans |
| Key components | Chaperones (e.g., HSPs), the proteasome, the autophagy-lysosome pathway, UPR/UPRmt responses |
| Status in aging biology | Formally recognized as one of the 'hallmarks of aging' |
| Link to autophagy | Autophagy is one of the main degradative arms of the proteostasis network |
| Effects of loss | Accumulation of protein aggregates linked in animal-model studies to neurodegenerative diseases |
Understand
Overview
Proteostasis (protein homeostasis) is a state of dynamic balance between protein synthesis, correct spatial folding, repair of damaged structures, and the degradation and recycling of those that can no longer be repaired. Maintaining this balance is the job of an extensive 'proteostasis network' — a set of molecular chaperones, degradation systems (the proteasome, the autophagy-lysosome pathway), and stress-response mechanisms that work together to prevent the accumulation of misfolded or damaged proteins.
Proteostasis is recognized as one of the key, interconnected mechanisms in the biology of aging — its capacity steadily declines with age, which in numerous studies on model organisms (yeast, fruit flies, nematodes, mice) is linked to the accumulation of protein aggregates characteristic of neurodegenerative diseases such as Alzheimer's or Parkinson's disease. Loss of proteostasis is formally listed in the scientific literature as one of the recognized 'hallmarks of aging.'
There is no simple, direct way to 'improve proteostasis' in humans — it isn't a single process that can be switched on with a supplement, but a broad network of overlapping mechanisms. The most practically relevant point for a biohacking-minded reader is that proteostasis is closely linked to autophagy — one of its main degradative arms — so factors that influence autophagy (fasting, caloric restriction, physical exercise) also indirectly affect the overall capacity of the proteostasis network.
Mechanism of action
The proteostasis network operates on three interconnected levels. The first is folding quality — molecular chaperones (e.g., the HSP family) help newly formed amino acid chains adopt their correct spatial structure and attempt to repair or refold proteins damaged by cellular stress. The second is selective degradation — proteins that cannot be repaired are tagged (e.g., via ubiquitination) and directed to the proteasome (for single, soluble proteins) or to autophagy (for larger aggregates and damaged organelles), where they end up in the lysosome and are broken down. The third is stress-response programs — such as the response to misfolded proteins in the endoplasmic reticulum (UPR) or in mitochondria (UPRmt) — which, under conditions of cellular overload, further boost chaperone production and degradation capacity.
With age, the capacity of all three levels declines simultaneously: chaperone expression decreases, proteasome activity diminishes, and autophagy and the lysosomes become less efficient. Because these systems are interlinked (e.g., the proteasome and autophagy partially compensate for each other), their combined weakening creates a vicious cycle — a growing amount of damaged protein places additional strain on an already weaker degradation network. It is this cumulative effect, rather than the failure of a single mechanism, that is considered central to age-related loss of proteostasis.
Chaperone-assisted folding
Molecular chaperones help newly formed amino acid chains adopt their correct structure and attempt to repair proteins damaged by stress.
Selective degradation
Irreparable proteins are tagged and directed to the proteasome or to autophagy-lysosome, depending on the size and type of damage.
Activation of stress programs
Under cellular overload, additional responses (UPR, UPRmt) are triggered, boosting repair and degradation capacity.
Age-related decline in capacity
Simultaneous weakening of all three levels leads to a growing accumulation of damaged proteins and a vicious cycle of network overload.
Evidence: moderate — based on 2 studies in this database.
Benefits
Common myths
MythProteostasis can be 'improved' with a specific supplement the way you raise a vitamin level.
FactProteostasis is a network of many interdependent mechanisms (chaperones, the proteasome, autophagy, stress responses), not a single biochemical parameter — there is no validated intervention today that switches it on as a whole in humans.
MythProteostasis and autophagy are the same concept.
FactAutophagy is one component (one degradative arm) of the broader proteostasis network, alongside chaperones and the proteasome — it's an umbrella term, not a synonym.
Check your profile
Not sure which supplements actually make sense for you?
Answer a few short questions about your lifestyle, diet, sleep, and goals. VitMode will build your profile and show supplements worth considering — with reasoning and evidence strength.
Recommendations take your answers and the strength of the scientific evidence into account. A supplement's popularity has no bearing on whether it gets recommended.
Practice
Frequently asked questions
Proteostasis is a broader concept covering the entire network of mechanisms that maintain protein balance (folding, repair, degradation), while autophagy is one of its components — a specific pathway for degrading damaged proteins and organelles.
There is no single, simple clinical test — assessing proteostasis requires combining many indirect indicators (e.g., markers of protein aggregation, proteasome activity), which limits its use outside of scientific research.
Fasting boosts autophagy, which is one arm of the proteostasis network, so it may indirectly support this mechanism — but direct clinical evidence of improvement to the entire proteostasis network in humans is still lacking.
In studies on animal models and cell lines, impaired proteostasis is linked to the accumulation of protein aggregates typical of neurodegenerative diseases, but this is a complex relationship, not a simple cause-and-effect link confirmed clinically in humans.
What to combine with
Good combinations
Autophagy — Autophagy is one of the main degradative mechanisms that make up the broader proteostasis network
Lysosomal Health — Lysosomes are the final degradation point for autophagy-dependent proteostasis
Safety
Side effects & contraindications
Possible side effects
Contraindications
No significant contraindications at typical doses.
Is it worth taking?
Who it's for
- People interested in the molecular biology of cellular aging
- People wanting to understand the broader context in which autophagy and other cellular 'housekeeping' mechanisms operate
Not for
- No significant contraindications at typical doses.
Evidence
Worth knowing
Loss of proteostasis is formally listed in the scientific literature as one of the recognized 'hallmarks of aging.'
The proteostasis network includes at least three cooperating systems: chaperones, the proteasome, and the autophagy-lysosome pathway.
Studies
The proteostasis network and its decline in ageing
Moderate evidenceHipp MS, Kasturi P, Hartl FU · Nature Reviews Molecular Cell Biology · 2019
An extensive review describing the structure of the proteostasis network (chaperones, the proteasome, autophagy) and the mechanisms of its gradual weakening with age, linked to neurodegenerative diseases.
View studyPathways of cellular proteostasis in aging and disease
Moderate evidenceKlaips CL, Jayaraj GG, Hartl FU · Journal of Cell Biology · 2018
A review of cellular proteostasis pathways and evidence for their role in aging and diseases linked to protein aggregation, based largely on studies in model organisms and cell lines.
View studySources & bibliography
The PubMed identifiers in this knowledge base were checked against NCBI records (October 2026). If you spot an error in a source, please let us know via the contact form.
Compare with similar entries
About the authors of this entry
Author
dr Anna KowalczykEditor-in-Chief, Molecular Biology
Anna studied molecular biology at the University of Warsaw, then spent eight years after her PhD in a lab researching the mechanisms of cellular aging and autophagy. She stumbled into science journalism almost by accident — frustrated by how easily her field's findings get oversimplified in the media, she started a blog explaining the biology of aging in plain language. That blog became the seed of VitMode. Today Anna oversees the entire editorial process, holding every piece to the same rigor her old lab demanded: primary sources, methodology checks, and honesty about the limits of the evidence. Outside work, she's a dedicated boulderer.
227 publications on this site
Medical review
dr Piotr ZielińskiEndocrinologist
Piotr has practiced endocrinology for more than fifteen years, mostly in male hormonal disorders and metabolic health. He joined VitMode as a scientific consultant because, as he jokes, he got tired of explaining the same testosterone questions at every appointment and decided to write the answers down properly, once. He reviews content on hormone therapy, supplement pharmacology and drug interactions, making sure articles never turn into encouragement to self-supplement in situations that genuinely need diagnostics and medical supervision. His professional motto — "evidence first, enthusiasm second" — has come up more than once with a patient who arrived with a supplement plan they found online.
297 publications on this site
Related entries
4.3Autophagy
An intracellular 'housekeeping' process that clears out damaged proteins and organelles, whose discovery earned a Nobel Prize — one of the key mechanisms studied in the context of slowing aging.
4.0UPRmt
The mitochondrial unfolded protein response (UPRmt) is an intracellular repair program that protects mitochondria from stress — linked to lifespan extension in model organisms, though the relationship turned out to be more complex than initially thought.
4.2TFEB
The transcription factor TFEB acts as a master on-off switch for autophagy and the production of new lysosomes in the cell — one of the best-characterized molecular nodes linking these two processes, studied as a potential target for interventions in aging.
3.9Lysosomal Health
Lysosomes — the cell's 'recycling centers' — accumulate unprocessed waste and lose capacity with age, a pattern increasingly described as one of the fundamental, shared denominators of cellular aging and a potential target for future interventions.
4.0Mitophagy
A selective form of autophagy in which the cell recognizes and removes specifically damaged, dysfunctional mitochondria — a mitochondrial quality-control mechanism whose efficiency declines with age and is studied in the context of neurodegenerative disease.
4.3Inflammaging
Chronic, low-grade, systemic inflammation that accompanies aging even without an active infection — a term coined in 2000 by Claudio Franceschi, today considered one of the fundamental mechanisms linking aging to age-related disease.
Related articles
PoradnikiIntermittent Fasting 16:8 or 5:2 — Which Eating Window Should You Choose
Intermittent fasting has spawned dozens of variants, but two protocols have dominated the public imagination: the daily, restricted 16:8 eating window and the cyclical, stronger calorie restriction of the 5:2 method. This guide compares both approaches based on real clinical trials, showing that the choice between them rarely comes down to which one is 'better' — and more often to which one you can actually stick with for longer than a few weeks.
September 3, 2026
PoradnikiSpermidine and Autophagy: What Animal Studies and Early Human Trials Actually Show
Spermidine is a natural polyamine present in every cell of our body, whose levels steadily decline with age. It's one of the few natural compounds with real, repeated mechanistic evidence of autophagy activation and a large observational study linking higher intake to lower mortality. But it's also a good example of how a promising result from a small human pilot trial (30 people) failed to hold up in a larger, better-designed trial (100 people) run by the same team. We take a close look at what each study actually showed, and where the limits of our current knowledge lie.
September 9, 2026
PoradnikiFisetin as a Senolytic: What the Mouse Study Showed and Where Human Research Stands Today
Fisetin is a flavonoid found in strawberries, apples, and onions that made longevity-media headlines in 2018 as the strongest of the studied natural senolytics — compounds that selectively clear senescent (aging) cells. The mouse result was genuinely strong: extended lifespan and reduced markers of aging across many tissues. The problem is that several years have passed since that study, and clinical trials in humans are still at the stage of pilot safety trials, not confirmed efficacy. We take a close look at what is actually known and what remains only a promising hypothesis.
September 9, 2026
PoradnikiQuercetin as a Senolytic: What the First Human Studies of the Dasatinib + Quercetin Combination Show
Quercetin, the same flavonoid we covered in an earlier article in the context of allergic rhinitis, plays an entirely different, far more experimental role in aging biology: as part of a combination with the oncology drug dasatinib (the "D+Q" protocol), studied as a senolytic — a substance that selectively clears senescent cells. This is the first pair of senolytic compounds for which real data have been published showing a reduction in senescent cells in humans, not just in animals. We take a close look at what these first clinical trials actually showed, what role quercetin itself actually plays in them, and where the limits of this evidence lie.
September 9, 2026
PoradnikiDasatinib and Quercetin (D+Q): Why an Oncology Drug Was Paired With a Flavonoid, and What It Actually Means
The D+Q protocol — dasatinib, an oncology drug used in chronic myeloid leukemia, combined with quercetin, a widely available flavonoid — is today's best-studied senolytic combination in humans. Our earlier articles on fisetin and on quercetin as senolytics covered the same pilot trials from a different angle. Here we focus on the question those pieces skipped: why dasatinib, a drug with real, non-trivial toxicity, became quercetin's partner, and what the 'hit-and-run' dosing logic behind the whole protocol actually means.
October 10, 2026
Comments (2)
- KW
Kasia W. 2 weeks ago
Very clearly explained, especially the interactions section — I hadn't seen it laid out this well anywhere else.
- MT
Marek T. a month ago
Are you planning to update this with the newest study from this year? I saw an interesting meta-analysis.